Group One Trading
XBIT icon

Group One Trading’s XBiotech XBIT Stock Holding History

Group One Trading’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,500
Closed -$29.6K – 8472
2024
Q4 		$29.6K Buy
+7,500
New +$51.1K ﹤0.01% 5442
2023
Q4 		– Sell
-1,738
Closed -$7.16K – 8298
2023
Q3 		$7.16K Buy
1,738
+1,572
+947% +$7.87K ﹤0.01% 6531
2023
Q2 		$986 Buy
+166
New +$749 ﹤0.01% 7258
2022
Q3 		– Sell
-4,000
Closed -$23K – 8347
2022
Q2 		$23K Buy
4,000
+3,500
+700% +$23.5K ﹤0.01% 6197
2022
Q1 		$4K Buy
+500
New +$5.02K ﹤0.01% 7566
2021
Q4 		– Sell
-2,024
Closed -$26.3K – 8935
2021
Q3 		$26K Buy
+2,024
New +$32.2K ﹤0.01% 7022
2021
Q2 		– Sell
-12,999
Closed -$220K – 8635
2021
Q1 		$223K Sell
12,999
-7,230
-36% -$135K ﹤0.01% 4909
2020
Q4 		$317K Sell
20,229
-4,600
-19% -$84.8K ﹤0.01% 3694
2020
Q3 		$474K Buy
24,829
+2,333
+10% +$40.3K ﹤0.01% 2898
2020
Q2 		$308K Buy
22,496
+9,372
+71% +$132K ﹤0.01% 3022
2020
Q1 		$139K Buy
13,124
+12,413
+1,746% +$202K ﹤0.01% 3037
2019
Q4 		$13K Sell
711
-12,190
-94% -$157K ﹤0.01% 4527
2019
Q3 		$135K Buy
12,901
+6,395
+98% +$52.1K ﹤0.01% 3356
2019
Q2 		$49K Buy
6,506
+2,204
+51% +$19.2K ﹤0.01% 3791
2019
Q1 		$47K Sell
4,302
-14,029
-77% -$114K ﹤0.01% 3600
2018
Q4 		$93K Buy
18,331
+1,220
+7% +$5K ﹤0.01% 3210
2018
Q3 		$54K Sell
17,111
-12,031
-41% -$46.9K ﹤0.01% 3936
2018
Q2 		$131K Buy
29,142
+13,377
+85% +$60.4K ﹤0.01% 3379
2018
Q1 		$84K Sell
15,765
-6,600
-30% -$30.4K ﹤0.01% 3354
2017
Q4 		$88K Sell
22,365
-26,606
-54% -$112K ﹤0.01% 3428
2017
Q3 		$214K Buy
48,971
+40,392
+471% +$191K ﹤0.01% 2712
2017
Q2 		$40K Buy
+8,579
New +$82.2K ﹤0.01% 3617
2017
Q1 		– Sell
-2,279
Closed -$29.8K – 5053
2016
Q4 		$23K Sell
2,279
-5,924
-72% -$78.8K ﹤0.01% 3654
2016
Q3 		$110K Buy
+8,203
New +$120K ﹤0.01% 2869

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's XBIT Position: Q1 2025 in Review

Group One Trading sold out of XBiotech (XBIT) in Q1 2025, closing a stake of 7,500 shares — an estimated $29.6K sold.

Group One Trading first reported a position in XBIT in Q3 2016 and held it in 24 quarters. The position peaked at $474K in Q3 2020. 55 funds tracked by Wall St. Rank hold XBIT as of Q1 2025.

  • Group One Trading reported no remaining XBiotech position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 7,500 XBiotech shares in Q1 2025, an estimated $29.6K.
  • Group One Trading first reported a position in XBiotech in Q3 2016 and held it in 24 quarters.
  • Group One Trading's XBiotech position peaked at $474K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held XBiotech as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.